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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe number of stem/progenitor cells available can profoundly impact tissue homeostasis and the response to injury or disease. Here, we
propose that an atypical PKC, Prkci, is a key player in regulating the switch from an expansion to a differentiation/maintenance phase via
regulation of Notch, thus linking the polarity pathway with the control of stem cell self-renewal. Prkci is known to influence symmetric
cell division in invertebrates; however a definitive role in mammals has not yet emerged. Using a genetic approach, we find that loss of
Prkci results in a marked increase in the number of various stem/progenitor cells. The mechanism used likely involves inactivation and
symmetric localization of NUMB, leading to the activation of NOTCH1 and its downstream effectors. Inhibition of atypical PKCsmay be
useful for boosting the production of pluripotent stem cells, multipotent stem cells, or possibly even primordial germ cells by promoting
the stem cell/progenitor fate.INTRODUCTION
The control of asymmetric versus symmetric cell division
in stem and progenitor cells balances self-renewal and dif-
ferentiation to mediate tissue homeostasis and repair and
involves key proteins that control cell polarity. In the
case of excess symmetric division, too many stem-cell-like
daughter cells are generated that can lead to tumor initia-
tion and growth. Conversely, excess asymmetric cell divi-
sion can severely limit the number of cells available for
homeostasis and repair (Go´mez-Lo´pez et al., 2014; Inaba
and Yamashita, 2012). The Notch pathway has been impli-
cated in controlling stem cell self-renewal in a number of
different contexts (Hori et al., 2013). However, how cell po-
larity, asymmetric cell division, and the activation of deter-
minants ultimately impinges upon the control of stem cell
expansion andmaintenance is not fully understood. In this
study, we examine the role of an atypical protein kinase C
(aPKC), PRKCi, in stem cell self-renewal and, in particular,
determine whether PRKCi acts via the Notch pathway.
PKCs are serine-threonine kinases that control many
basic cellular processes and are typically classified into
three subgroups—conventional, novel, and the aPKCs
iota and zeta, which, in contrast to the others, are not acti-
vated by diacylglyceride or calcium. The aPKC proteins are
best known for being central components of an evolution-
arily conserved Par3-Par6-aPKC trimeric complex that
controls cell polarity in C. elegans, Drosophila, Xenopus, ze-
brafish, and mammalian cells (Suzuki and Ohno, 2006).
Before Notch influences stem cell self-renewal, the regu-
lation of cell polarity, asymmetric versus symmetric cell di-866 Stem Cell Reports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 Thevision, and the segregation of cell fate determinants such as
NUMBmay first be required (Knoblich, 2008). For example,
mutational analysis in Drosophila has demonstrated that
the aPKC-containing trimeric complex is required for
maintaining polarity and for mediating asymmetric cell di-
vision during neurogenesis via activation and segregation
of NUMB (Wirtz-Peitz et al., 2008). NUMB then functions
as a cell fate determinant by inhibiting Notch signaling
and preventing self-renewal (Wang et al., 2006). In mam-
mals, the PAR3-PAR6-aPKC complex also can bind and
phosphorylate NUMB in epithelial cells and can regulate
the unequal distribution of Numb during asymmetric cell
division (Smith et al., 2007). During mammalian neuro-
genesis, asymmetric division is also thought to involve
the PAR3-PAR6-aPKC complex, NUMB segregation, and
NOTCH activation (Bultje et al., 2009).
Mice deficient in Prkcz are grossly normal, with mild de-
fects in secondary lymphoid organs (Leitges et al., 2001). In
contrast, deficiency of the Prkci isozyme results in early em-
bryonic lethality at embryonic day (E)9.5 (Seidl et al., 2013;
Soloff et al., 2004). A few studies have investigated the
conditional inactivation of Prkci; however, no dramatic
changes in progenitor generationwere detected in hemato-
poietic stem cells (HSCs) or the brain (Imai et al., 2006; Sen-
gupta et al., 2011), although one study found evidence of
a role for Prkci in controlling asymmetric cell division in
the skin (Niessen et al., 2013). Analysismay be complicated
by functional redundancy between the iota and zeta iso-
forms and/or because further studies perturbing aPKCs in
specific cell lineages and/or at specific developmental
stages are needed. Therefore, a complete picture for theAuthors
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Figure 1. Prkci/ EBs Contain Cells with Pluripotency Characteristics
(A and A0) Day (d) 12 heterozygous EBs have few OCT4/E-CAD+ cells, while null EBs contain many in clusters at the EB periphery. Inset:
OCT4 (nucleus)/E-CAD (cytoplasm) double-positive cells.
(B and B0) Adjacent sections in a null EB show that OCT4+ cells are likely also SSEA1+.
(C) Dissociated day-12 Prkci/ EBs contain five to six times more OCT4+ and approximately three times more SSEA1+ cells than het-
erozygous EBs (three independent experiments).
(D and D0) After 2 days in ES cell culture, no colonies are visible in null SSEA1 cultures while present in null SSEA1+ cultures (red arrows).
(E–E0 0) SSEA1+ sorted cells can be maintained for many passages, 27+. (E) Prkci+/ sorted cells make colonies with differentiated cells at
the outer edges (n = 27/35). (E0) Null cells form colonies with distinct edges (n = 39/45). (E0 0) The percentage of undifferentiated colonies
is shown. ***p < 0.001.
(legend continued on next page)
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requirement of aPKCs at different stages of mammalian
development has not yet emerged.
Here, we investigate the requirement of Prkci in mouse
cells using an in vitro system that bypasses early embryonic
lethality. Embryonic stem (ES) cells are used to make
embryoid bodies (EBs) that develop like the early post-im-
plantation embryo in terms of lineage specification and
morphology and can also be maintained in culture long
enough to observe advanced stages of cellular differentia-
tion (Desbaillets et al., 2000). Using this approach, we pro-
vide genetic evidence that inactivation of Prkci signaling
leads to enhanced generation of pluripotent cells and
some types of multipotent stem cells, including cells with
primordial germ cell (PGC) characteristics. In addition,
we provide evidence that aPKCs ultimately regulate stem
cell fate via the Notch pathway.RESULTS
Prkci/ Cultures Have More Pluripotent Cells Even
under Differentiation Conditions
First, we compared Prkci null EB development to that of
Prkci/ embryos. Consistent with another null allele (Seidl
et al., 2013), both null embryos and EBs fail to properly
cavitate (Figures S1A and S1B). The failure to cavitate is un-
likely to be due to the inability to form one of the three
germ layers, as null EBs express germ-layer-specific genes
(Figure S1E). A failure of cavitation could alternatively be
caused by an accumulation of pluripotent cells. For
example, EBs generated from Timeless knockdown cells
do not cavitate and contain large numbers of OCT4-ex-
pressing cells (O’Reilly et al., 2011). In addition, EBs gener-
ated with Prkcz isoform knockdown cells contain OCT4+
cells under differentiation conditions (Dutta et al., 2011;
Rajendran et al., 2013). Thus, we first evaluated ES colony
differentiation by alkaline phosphatase (AP) staining. After
4 days without leukemia inhibitory factor (LIF), Prkci/ ES
cell colonies retained crisp boundaries and strong AP
staining. In contrast, Prkci+/ colonies had uneven colony
boundaries with diffuse AP staining (Figures S1F–S1F0 0).
To definitively detect pluripotent cells, day-12 EBs were
assayed for OCT4 and E-CADHERIN (E-CAD) protein
expression. Prkci+/ EBs had very few OCT4/E-CAD dou-
ble-positive cells (Figure 1A); however, null EBs contained
large clusters of OCT4/E-CAD double-positive cells, con-
centrated in a peripheral zone (Figure 1A0). By examining(F) Sorted null cells express stem cell and differentiation markers at
independent experiments).
(G) EBs made from null SSEA1+ sorted cells express germ layer marke
Error bars indicate mean ± SEM, three independent experiments. Sca
See also Figure S1.
868 Stem Cell Reports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 Theadjacent sections, we found that OCT4+ cells could also
be positive for stage-specific embryonic antigen 1 (SSEA1)
(Figures 1B and 1B0). Quantification by fluorescence-acti-
vated cell sorting (FACS) analysis showed that day-12
Prkci/ EBs had more OCT4+ and SSEA1+ cells than
Prkci+/ EBs (Figure 1C). We did not find any difference be-
tween heterozygous and wild-type cells with respect to the
number of OCT4+ or SSEA1+ cells or in their levels of
expression for Oct4, Nanog, and Sox2 (Figures S1I, S1I0 and
S1J). However, we did find that Oct4, Nanog, and Sox2
were highly upregulated in OCT4+ null cells (Figure S1G).
Thus, together, these data indicate that Prkci/ EBs
contain large numbers of pluripotent stem cells, despite be-
ing cultured under differentiation conditions.
Functional Pluripotency Tests
If primary EBs have a pluripotent population with the ca-
pacity to undergo self-renewal, they can easily form sec-
ondary EBs (O’Reilly et al., 2011). Using this assay, we
found that more secondary EBs could be generated from
Prkci/ versus Prkci+/ EBs, especially at days 6, 10, and
16; even when plated at a low density to control for aggre-
gation (Figure S1H). To test whether SSEA1+ cells could
maintain pluripotency long term, FACS-sorted Prkci/
SSEA1+ and SSEA1 cells were plated at a low density
and maintained under ES cell culture conditions. SSEA1
cells were never able to form identifiable colonies and
could not be maintained in culture (Figure 1D). SSEA1+
cells, however, formed many distinct colonies after 2 days
of culture, and these cells could be maintained for over
27 passages (Figures 1D0, 1E0, and 1E0 0). Prkci+/ SSEA1+ cells
formed colonies that easily differentiated at the outer edge,
even in the presence of LIF (Figure 1E). In contrast Prkci/
SSEA1+ cells maintained distinct round colonies (Fig-
ure 1E0). Next, we determined whether null SSEA1+ cells
expressed pluripotency and differentiation markers simi-
larly to normal ES cells. Indeed, we found that Oct4,Nanog,
and Sox2were upregulated in both null SSEA1+ EB cells and
heterozygous ES cells. In addition, differentiated markers
(Fgf5, T, Wnt3, and Afp) and tissue stem/progenitor cell
markers (neural: Nestin, Sox1, and NeuroD; cardiac: Nkx2-5
and Isl1; and hematopoietic: Gata1 and Hba-x) were
downregulated in both SSEA1+ cells and heterozygous ES
cells (Figure 1F). SSEA1+ cells likely have a wide range of
potential, since EBs generated from these cells expressed
markers for all three germ layers (Figure 1G). In addition,
as expected, EBs made from null SSEA1+ cells weresimilar levels to normal ES cells (versus heterozygous EBs) (three
r genes at the indicated days.
le bars, 100 mm in (A, D, and E); 25 mm in (B).
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Figure 2. Prkci and Pluripotency Pathways
(A) ERK1/2 phosphorylation (Y202/Y204) is
reduced in null ES cells and early day (d)-6
null EBs compared to heterozygous EBs and
strongly increased at later stages. The first
lane shows ES cells activated (A) by serum
treatment 1 day after serum depletion.
(B) Quantification of pERK1/2 normalized
to non-phosphorylated ERK1/2 (three
independent experiments; mean ± SEM;
**p < 0.01).
(C) pERK1/2 Y202/Y204 is strongly expressed in
the columnar epithelium of heterozygous
EBs that have just cavitated. Null EBs
have lower expression. OCT4 and pERK1/2
expression do not co-localize. Scale bar,
100 mm.
(D) pERK1/2Y202/Y204 levels are lower in null
SSEA1+ sorted cells than in heterozygous or
in null day-12 EBs that have undergone
further differentiation. pSTAT3 and STAT
levels are unchanged.
See also Figure S2.morphologically abnormal, similar to the EBs made from
unsorted Prkci/ ES cells (Figure S1G0). Thus, taken
together, several assays indicate that the OCT4 and
SSEA1+ populations enriched in null EBs represent plurip-
otent stem cells that can self-renew and have broad differ-
entiation capacity.
ERK1/2 Signaling during EB Development
Stem cell self-renewal has been shown to require the activa-
tion of the JAK/STAT3 and PI3K/AKT pathways and the in-
hibition of ERK1/2 and GSK3 pathways (Kunath et al.,
2007; Niwa et al., 1998; Sato et al., 2004; Watanabe et al.,
2006). We found that both STAT3 and phosphorylated
STAT3 levels were not grossly altered and that the
p-STAT3/STAT3 ratio was similar between heterozygous
and null ES cells and EBs (Figures S2A and S2B). In addition
we did not see any difference in AKT, pAKT, or b-CATENIN
levels when comparing heterozygous to null ES cells or EBs
(Figures S2A and S2C). Thus, the effects observed by the
loss of Prkci are unlikely to be due to a significant alteration
in the JAK/STAT3, PI3K/AKT, or GSK3 pathways.
Next, we investigated ERK1/2 expression and activation.
Consistent with other studies showing ERK1/2 activation
to be downstream of Prkci in some mammalian cell types
(Boeckeler et al., 2010; Litherland et al., 2010), pERK1/2
was markedly inactivated in Prkci null versus heterozygous
ES cells. In addition, during differentiation, null EBs dis-
played strong pERK1/2 inhibition early (until day 6). Later,
pERK1/2 was activated strongly, as the EB began dif-
ferentiating (Figures 2A and 2B). By immunofluorescence,
pERK1/2 was strongly enriched in the columnar epithe-Stem Cell Rlium of control EBs, while overall levels were much lower
in Prkci/ EBs (Figure 2C). In addition, high OCT4 expres-
sion correlated with a marked inactivation of pERK1/2
(Figure 2C). Next, we examined Prkci/ SSEA1+ cells by
western blot. We found that SSEA1+ cells isolated from
day-12 null EBs had pSTAT3 expression levels similar to
whole EBs, while pERK1/2 levels were low (Figure 2D).
Thus, these experiments indicate that the higher numbers
of pluripotent cells in null EBs correlate with a strong inac-
tivation of ERK1/2.
Neural Stem Cell Fate Is Favored in Prkci/ EBs
It is well known that ERK/MEK inhibition is not sufficient
for pluripotent stem cell maintenance (Ying et al., 2008);
thus, other pathways are likely involved. Therefore, we
used a TaqMan Mouse Stem Cell Pluripotency Panel
(#4385363) on an OpenArray platform to investigate the
mechanism of Prkci action. Day 13 and day 20 Prkci/
EBs expressed high levels of pluripotency and stemness
markers versus heterozygous EBs, including Oct4, Utf1,
Nodal, Xist, Fgf4, Gal, Lefty1, and Lefty2. However, interest-
ingly, EBs also expressed markers for differentiated cell
types and tissue stem cells, including Sst, Syp, and Sycp3
(neural-related genes), Isl1 (cardiac progenitor marker),
Hba-x, and Cd34 (hematopoietic markers). Based on this
first-pass test, we sought to determine whether loss of Prkci
might favor the generation of neural, cardiac, and hemato-
poietic cell types and/or their progenitors.
First, we found that null EBs contained many more
NESTIN- and PAX6-positive cells than heterozygous EBs
(Figures 3A and 3B; Figures S3A and S3B) (neural stemeports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 The Authors 869
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Figure 3. Neural Stem Cell Populations
Are Increased in Null EBs
(A–C0) Prkci/ EBs (B) have more NESTIN-
positive cells than Prkci+/ EBs (A). (C and
C0) MAP2 and TUJ1 are expressed in null
EBs, similarly to heterozygous EBs (data not
shown).
(D) EBs were assessed for PAX6 expression,
and the images were used for quantification
(Figures S3A and S3B). The pixel count ratio
of PAX6+ cells in null EBs (green) is sub-
stantially higher than that found in het-
erozygous EBs (black) (three independent
experiments; mean ± SEM; *p < 0.05).
(E–F0 0 0) Day 4 after RA treatment, Prkci/
EBs have more NESTIN- than TUJ1-positive
neurons (E and F). However, null cells can
still terminally differentiate into NEUROD-,
NEUN-, and MAP2-positive cells (F0–F0 0 0).
Scale bars, 25 mm in (A and C) and 50 mm
in (E).
See also Figure S3.and progenitor markers) (Sansom et al., 2009; Tohyama
et al., 1992). In addition, quantification of PAX6 immuno-
fluorescence (easier to quantify because of its nuclear local-
ization) using a pixel count method (Fogel et al., 2012)
revealed more abundant PAX6+ cells in null EBs versus
heterozygous EBs. This difference was no longer evident
at day 16, presumably because most of the new neural pro-
genitors had differentiated (Figure 3D). Indeed, differenti-
ated neuronal markers MAP2 and TUJ1 could be expressed
in null cell cultures (Figures 3C and 3C0). Retinoic acid (RA)
treatment both in EBs and ES cells promotes neurogenesis
(Xu et al., 2012). We found that, even under RA induction,
null cultures contained a larger population of NESTIN+ and
a smaller population of TUJ1+ cells when compared to het-
erozygous cultures (Figures 3E and 3F). Again, null neural
progenitors were capable of undergoing some differentia-
tion, since we could find cells expressing NEUROD,
NEUN, and MAP2 (Figures 3F0–3F0 0 0). We also assessed neu-
rogenesis inmonolayer culture, usingmedia that promotes
neural stem cell generation supplemented with a low con-
centration of RA (Xu et al., 2012). Similar to the EB assay,
we found that null ES cells generated a larger NESTIN+
and smaller TUJ1+ population compared to heterozygous
ES cells (Figures S3C and S3D). Like in EBs, MAP2- and
TUJ1-positive cells could still be found in the null cultures870 Stem Cell Reports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 The(Figure S3D0). Thus, using several different neural-induc-
tion assays, we found that the absence of Prkci correlates
with the production of more neural progenitors and that,
although these cells may favor self-renewal, they are still
capable of progressing toward differentiation.
The Generation of Cardiomyocyte and Erythrocyte
Progenitors Is Also Favored
Next, we examined ISL1 expression (a cardiac stem cell
marker) by immunofluorescence and found that Prkci/
EBs contained larger ISL1 clusters compared with Prkci+/
EBs; this was confirmed using an image quantification
assay (Figures 4A, 4A0, and 4C). Differentiated cardiac cells
and ventral spinal neurons can also express ISL1 (Ericson
et al., 1992); therefore, we also examined Nkx2-5 expres-
sion, a better stem cell marker and regulator of cardiac pro-
genitor determination (Brown et al., 2004), by RT-PCR and
immunofluorescence. In null EBs, Nkx2-5 was upregulated
(Figure 4D). In addition, in response to RA, which can pro-
mote cardiac fates in vitro (Niebruegge et al., 2008), cells
expressing NKX2-5 were more prevalent in null versus het-
erozygous EBs (Figures 4B and 4B0).The abundant cardiac
progenitors found in null EBs were still capable of undergo-
ing differentiation (Figures 4E–4F0). Indeed, more cells ex-
hibited the striated pattern characteristic of a-ACTININ inAuthors
Figure 4. Cardiomyocyte and Erythrocyte Progenitors Are Increased in Prkci/ EBs
(A–F0) In (A, A0, E, and E0), Prkci/ EBs cultured without LIF have more ISL1 (cardiac progenitor marker) and a-ACTININ-positive
cells compared to heterozygous EBs. (C) At day (d) 9, the pixel count ratio for ISL1 expression indicates that null EBs (green) have larger
ISL1 populations than heterozygous EBs (black) (three independent experiments, n = 20 heterozygous EBs, 21 null EBs total; mean ± SEM;
*p < 0.05). In (B, B0, D, F, and F0), RA treatment induces more NKX2-5 (both nuclear and cytoplasmic) and a-ACTININ expression in
null EBs. Arrows point to fibers in (F0).
(G) Null EBs (green) generate more beating EBs with RA treatment compared to heterozygous EBs (black) (four independent experiments;
mean ± SEM; *p < 0.05, ***p < 0.001).
(H) Dissociated null EBs of different stages (green) generate more erythrocytes in a colony-forming assay (CFU-E) (four independent
experiments; mean ± SEM; **p < 0.01).
(I) Examples of red colonies.
(J) Gene expression for primitive HSC markers is upregulated in null EBs (relative to heterozygous EBs) (three independent experiments;
mean ± SEM).
Scale bars, 50 mm in (A, B, and E); 100 mm in (F), and 25 mm in (I).
See also Figure S4.
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null versus heterozygous EBs with RA induction (Figures 4F
and 4F0). In addition, many more Prkci/ EBs were beating
after days 6 and 12 of culture (Figure 4G).
Hba-x expression is restricted to yolk sac blood islands
and primitive erythrocyte populations (Lux et al., 2008;
Trimborn et al., 1999). Cd34 is also a primitive HSCmarker
(Sutherland et al., 1992). Next, we determined whether
the elevated expression of these markers observed with
OpenArray might represent higher numbers of primitive
hematopoietic progenitors. Using a colony-forming assay
(Baum et al., 1992), we found that red colonies (indicative
of erythrocyte differentiation; examples in Figure 4I) were
produced significantly earlier and more readily from cells
isolated from null versus heterozygous EBs (Figure 4H).
By quantitative real-time PCR, upregulation of Hba-x and
Cd34 genes confirmed the OpenArray results (Figure 4J).
In addition, we foundGata1, an erythropoiesis-specific fac-
tor, and Epor, an erythropoietin receptor that mediates
erythroid cell proliferation and differentiation (Chiba
et al., 1991), to be highly upregulated in null versus hetero-
zygous EBs (Figure 4J). These data suggest that the loss of
Prkci promotes the generation of primitive erythroid pro-
genitors that can differentiate into erythrocytes.
To determine whether the aforementioned tissue stem
cells identified were represented in the OCT4+ population
that we described earlier, we examined the expression of
PAX6, ISL1, and OCT4 in adjacent EB sections. We found
that cells expressing OCT4 appeared to represent a distinct
population from those expressing PAX6 and ISL1
(although some cells were PAX6 and ISL1 double-positive)
(Figures S4A–S4C).
Prkci/ Cells Are More Likely to Inherit
NUMB/aNOTCH1 Symmetrically
The enhanced production of both pluripotent and tissue
stem cells suggests that the mechanism underlying the ac-
tion of Prkci in these different contexts is fundamentally
similar. Because the Notch pathway controls stem cell
self-renewal in many contexts (Hori et al., 2013), and
because previous studies implicated a connection between
PRKCi function and the Notch pathway (Bultje et al., 2009;
Smith et al., 2007), we examined the localization and acti-
vation of a key player in the Notch pathway, NUMB, (Inaba
and Yamashita, 2012). Differences in NUMB expression
were first evident in whole EBs, where polarized expression
was evident in the ectodermal and endodermal epithelia of
heterozygous EBs, while Prkci/ EBs exhibited amore even
distribution (Figures 5A–5B0). To more definitively deter-
mine the inheritance of NUMB during cell division, dou-
blets undergoing telophase or cytokinesis were scored for
symmetric (evenly distributed in both cells) or asymmetric
(unequally distributed) NUMB localization (examples: Fig-
ures 5C and 5C0). In dissociated day-10 EBs, Prkci+/872 Stem Cell Reports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 Thedoublets displayed somewhat less symmetric versus asym-
metric inheritance, while Prkci/ doublets exhibited
nearly four times more symmetric versus asymmetric in-
heritance (Figure 5D). Although individual cells from null
EBs that were OCT4+ or PAX6+ more likely to exhibit
non-polarized NUMB distribution (Figures S5A and S5B),
we decided to use an assay that allowed for FACS purifi-
cation, followed by the more stringent doublet assay.
Therefore, we chose CD24 (heat-stable antigen; BA-1), a
cell-surface marker that is highly expressed in pre-differen-
tiated neurons and neuroblasts (Pruszak et al., 2009), and
tested this marker as a method to enrich for cells destined
to differentiate into neurons (see Supplemental Experi-
mental Procedures). To assess NUMB localization, FACS-
sorted CD24 cells isolated from the RA-treated EBs
were then put in culture for 24 hr, and doublets were
scored. Both Prkci/ CD24high and CD24low doublets
exhibited more symmetric versus asymmetric NUMB
localizationwhen compared to Prkci+/ doublets (Figure 5E)
(>23 more was observed for CD24low doublets; 1.5 ± 0.25
[null] versus 0.67 ± 0.2 [heterozygous]). Thus, in summary,
loss of Prkci favors the generation of cells with symmetric
NUMB distribution, even during EB differentiation. In
addition, in situations where neurogenesis is stimulated
(RA treatment), loss of Prkci favors symmetric NUMB distri-
bution in both the CD24high/low subpopulations.
Because NUMB can be directly phosphorylated by aPKCs
(both PRKCi and PRKCz) (Smith et al., 2007; Zhou et al.,
2011), loss of Prkci might be expected to lead to decreased
NUMB phosphorylation. Three NUMB phosphorylation
sites—Ser7, Ser276, and Ser295—could be aPKC mediated
(Smith et al., 2007). By immunofluorescence, we found
that one of the most well-characterized sites (Ser276), was
strongly inactivated in null versus heterozygous EBs, espe-
cially in the core (Figures 5F and 5G). Western analysis also
confirmed that the levels of pNUMB (Ser276) were
decreased in null versus heterozygous EBs (Figure S5F).
Thus, genetic inactivation of Prkci leads to a marked
decrease in the phosphorylation status of NUMB.
Notch pathway inhibition by NUMB has been observed
in flies and mammals (Berdnik et al., 2002; French et al.,
2002). Therefore, we investigated whether reduced Numb
activity in Prkci/ EBs might lead to enhanced NOTCH1
activity and the upregulation of the downstream transcrip-
tional readouts (Meier-Stiegen et al., 2010). An overall in-
crease in NOTCH1 activation was supported by western
blot analysis showing that the level of activated NOTCH1
(aNOTCH1) was strongly increased in day 6 and day 10
null versus heterozygous EBs (Figure S5G). This was sup-
ported by immunofluorescence in EBs, where widespread
strong expression of aNOTCH1 was seen in most null cells
(Figures 5I and 5I0), while in heterozygous EBs, this pattern
was observed only in the OCT4+ cells (Figures 5H and 5H0).Authors
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Figure 5. Prkci/ Cells Preferentially Inherit Symmetric Localization of NUMB and aNOTCH1 and Notch Signaling Is Required for
Stem Cell Self-Renewal in Null Cells
(A–B0) In (A and B), day (d)-7 heterozygous EBs have polarized NUMB localization within epithelia and strong expression in the endoderm,
while null EBs have a more even distribution. (A0 and B0) Enlarged views.
(C and C0) Asymmetric and symmetric NUMB expression examples.
(legend continued on next page)
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To examine the localization of aNOTCH1 and to better
quantify the results seen in Figures 5H and 5I, doublets
from dissociated EBs were scored. As seen with NUMB
localization, null doublets were more likely to have sym-
metric localization of aNOTCH1 in comparison to hetero-
zygous doublets (Figure 5K; examples in Figures 5M and
5M0). In addition, both CD24high and CD24low doublets
from RA-treated null EBs were more likely to exhibit
symmetric aNOTCH1 distribution versus doublets from
RA-treated heterozygous EBs (Figure 5L; 3.46 ± 0.8 [null]
versus 0.59 ± 0.06 [heterozygous] in CD24low doublets).
In addition, by RT-PCR, the expression of Notch down-
stream genes Hes1, Hes5, Hey1, and Hey2 was increased in
null versus heterozygous EBs (Figure S5I). Furthermore,
HES5 by immunofluorescence was broadly expressed at
similar levels in both null and heterozygous cells (Figures
5J and 5J0; Figures S5H and S5H0) but more strongly
expressed in null OCT4+ cells (Figures 5J and 5J0). Thus,
loss of Prkci is associated with NOTCH1 activation,
aNOTCH1 symmetric localization, and the upregulation
of Hes/Hey downstream genes in several assays.
To determine whether Notch pathway activation is
required in the absence of Prkci, we examined AP activity
and OCT4 expression while blocking the Notch pathway
using DAPT to inhibit g-secretase (Sastre et al., 2001).
DMSO-treated null ES cells stayed undifferentiated
(sharp-edged colonies, strong AP staining); however, treat-(D) Doublets from day-10 null EBs have more symmetric inheritance w
experiments; mean ± SEM; **p < 0.01). A red line indicates a ratio o
(E) CD24high null doublets exhibited more symmetric NUMB inherita
periments; mean ± SEM; *p < 0.05). A red line indicates where the ra
(F and G) Decreased pNUMB (Ser276) is evident in the core of null ve
(H–I0) In (H and I), aNOTCH1 is strongly expressed in heterozygous E
expression is predominant in OCT4+ cells of null EBs (n = 10 of each gen
demarcated with dotted lines.
(J and J0) OCT4+ cells express HES5 strongly in the nucleus (three in
(K) Null doublets from dissociated EBs have more symmetric aNOTCH1
experiments; mean ± SEM; **p < 0.01). A red line indicates where th
(L) CD24high Prkci/ doublets exhibit more symmetric aNOTCH1 than
mean ± SEM; *p < 0.05). A red line indicates where the ratio is 1.
(M and M0) Examples of asymmetric and symmetric aNOTCH1 localizat
(N and O) Day-3 DMSO-treated null ES colonies show strong AP staining
to more differentiation in (O).
(P–R) OCT4 is strongly expressed in day-4 DMSO-treated null ES cultu
(S) Working model: In daughter cells that undergo differentiation, PRK
phosphorylated. The activation of NUMB then leads to an inhibition
nance program. In the absence of Prkci, the PAR3/PAR6 complex can
asymmetric localization and phosphorylation is reduced. Low levels of
NOTCH1 preserves the stem cell self-renewal program. We suggest that
an expansion phase that is symmetric to a differentiation and/or mai
low or absent PRKCi, we propose that the expansion phase is prolong
Scale bars, 50 mm in (A, B, F, G, H, I, J, J0, P–R); 200 mm in (A0 and
See also Figure S5.
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tiation (AP-negative cells with cellular extensions) (Figures
5N, 5O, and S5J). In addition, OCT4 is strongly expressed
in day-4 control ES cell cultures; however, in the presence
of DAPT, OCT4 expression is much decreased both in
monolayer culture (Figures 5P–5R) and in null EBs (48%
lower OCT4+ signal versus DMSO controls, pixel counting
on EB sections; data not shown). These results support the
idea that activated Notch signaling is required in the
absence of Prkci to see enhanced pluripotency.
Taken together, the combined effects of decreased NUMB
activation, favored symmetric distribution of NUMB and
aNOTCH1 and increased NOTCH1 activity support a
model whereby loss of Prkci leads to sustained generation
of pluripotent and some tissue stem cell populations (Fig-
ure 5S; and see Discussion).
Additional Loss of PRKCz Activity Boosts the Number
of OCT4-, SSEA1-, and STELLA-Positive Cells
The generation and maintenance of pluripotent stem cells
from new sources or tissue stem cells for basic or transla-
tional research can be challenging, and there is need for
new in vitro strategies. A PKC inhibitor (Go¨6983) that in-
hibits PKCa, -b, -g, -d, and -z has been used to help main-
tain mouse and rat ES cells in the absence of LIF (Dutta
et al., 2011; Rajendran et al., 2013). Thus, we hypothesized
that treating null cells with Go¨6983 might lead to betterhen compared to day-10 heterozygous doublets (three independent
f 1 (equal percent symmetric and asymmetric).
nce than CD24high heterozygous doublets (three independent ex-
tio is 1.
rsus heterozygous EBs (n = 10 of each genotype).
Bs, including both OCT4+ and OCT4 cells, while strong aNOTCH1
otype)). (H0 and I0) Enlarged views of boxed regions. OCT4+ cells are
dependent experiments).
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e ratio is 1.
CD24high heterozygous doublets (three independent experiments;
ion.
all the way to the colony edge in (N). Treatment with 3 mM DAPT led
res (P). With DAPT (Q,R), OCT4 expression is decreased.
Ci can associate with PAR3 and PAR6. NUMB is recruited and directly
in NOTCH1 activation and stimulation of a differentiation/mainte-
not assemble (although it may do so minimally with Prkcz). NUMB
pNUMB are not sufficient to block NOTCH1 activation, and activated
PRKCi functions to drive differentiation by pushing the switch from
ntenance phase that is predominantly asymmetric. In situations of
ed.
B0); 25 mm in (C, C0, M, and M0); and 100 mm in (H0, I0, N, and O).
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Figure 6. Additional Inhibition of PRKCz
Results in an Even Higher Percentage
of OCT4-, SSEA1-, and STELLA-Positive
Cells
(A and A0) After day 4 without LIF, hetero-
zygous ES cells undergo differentiation in
the presence of Go¨6983, while null ES cells
stay as distinct colonies in (A0).
(B and B0) Go¨6983 stimulates an increase
in OCT4+ populations in heterozygous EBs
and an even larger OCT4+ population in null
EBs in (B0, insets: green and red channels
separately).
(C–D0) An even higher percentage of cells
are OCT4+ (C and C0) and SSEA1+ (D and D0)
with Go¨6983 treatment (day 12, three in-
dependent experiments).
(E and F) More STELLA+ clusters containing
a larger number of cells are present in drug-
treated heterozygous EBs.
(G and H) Null EBs also have more STELLA+
clusters and cells. Drug-treated null EBs
exhibit a dramatic increase in the number of
STELLA+ cells.
(I–K) Some cells are double positive
for STELLA and VASA in drug-treated null
EBs (yellow arrows). There are also VASA-
only (green arrows) and STELLA-only cells
(red arrows) (three independent experi-
ments).
(L–P) Treatment with ZIP results in an in-
crease in OCT4+ and STELLA+ cells. ZIP
treatment also results in more cells that are
VASA+ (three independent experiments); n = 11 for Prkci+/, and n = 13 for Prkci+/ + ZIP; n = 14 for Prkci/, and n = 20 for Prkci/ + ZIP;
eight EBs assayed for both STELLA and VASA expression).
Scale bars, 100 mm in (A and A0); 50 mm in (B and B0); and 25 mm in (E, I, and L).
See also Figure S6.stem cell expansion compared to loss of just Prkci. In our
hands, we found that, under differentiation conditions
(no LIF), heterozygous ES cells treated with the inhibitor
for 4 days still underwent differentiation (Figure 6A), while
treated null ES cells largely stayed undifferentiated (Fig-
ure 6A0; Figure S6A). Drug treatment of heterozygous EBs
boosted the generation of OCT4-expressing cells (Fig-
ure 6B), while treatment of null EBs resulted in an even
larger OCT4+ population (Figure 6B0). NUMB localization
was also moderately affected (Figure S6B). By cell sorting,
we found that drug treatment significantly increased the
percentage of OCT4+ cells in both Prkci+/ and Prkci/
EBs (Figures 6C and 6C0; Figures S6C and S6C0). Interest-
ingly, Go¨6983 treatment also boosted the generation of
SSEA1+ cells in both null and heterozygous EBs (Figures
6D and 6D0; Figures S6D and S6D0).
SSEA1 is expressed in BLIMP1-positive PGCs derived
from mouse epiblast stem cells (Hayashi and Surani,Stem Cell R2009). Also, PGC-like cells can be derived from isolated
SSEA1+/OCT4+ EB cells (Geijsen et al., 2004). Therefore,
we speculated that the increase in SSEA1 and OCT4 due
to Go¨6983 treatment could represent an increase in the
generation of PGC-like cells instead of undifferentiated ES
cells. Therefore, we examined the expression of STELLA
(a PGC marker). As expected, heterozygous EBs contain
small clusters of STELLA+ cells similar to EBs made of
wild-type cells (Figure 6E) (Payer et al., 2006). The addition
of Go¨6983 to Prkci+/ EBs induced a modest increase in the
number of STELLA+ cells present in the clusters (Figure 6F).
Without drug treatment, null EBs contained more clusters,
and the clusters contained more STELLA+ cells when
compared to heterozygous EBs (Figures 6E and 6G). Inter-
estingly, when Prkci/ EBs were treated with Go¨6983, the
generation of STELLA+ cells was strongly enhanced (Fig-
ure 6G versus Figure 6H). Because undifferentiated ES cells
can still express STELLA (Payer et al., 2006), we co-stainedeports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 The Authors 875
EBs for VASA (amore differentiated PGCmarker).We found
many cells that were double positive (a little less than half)
(Figure 6K) but also cells that expressed VASA only and
STELLA only (23 more than VASA only) (Figures 6I–6K,
red/green arrows). Therefore, the combined effect of loss
of Prkci and PKC inhibition via Go¨6983 treatment leads
to the production of STELLA and VASA+ PGC-like cells.
Next, we examined whether the more specific aPKC in-
hibitor, ZIP, a myristolated aPKC pseudosubstrate with
competitive binding to p62, had similar effects (Price and
Ghosh, 2013; Tsai et al., 2015; Yao et al., 2013). We found
that both heterozygous and null EBs treated with ZIP
contained more OCT4+ cells compared to un-treated EBs
(Figures 6L–6O). In addition, likeGo¨6983, ZIP treatment re-
sulted in a modest increase in the percentage of SSEA1+
cells found in heterozygous EBs and a strong increase in
the percentage of SSEA1+ cells in null EBs (Figures S6E–
S6F0). Furthermore, like Go¨6983, both STELLA+ and
VASA+ populations were increased with ZIP treatment (Fig-
ure 6P). Thus, both pluripotent and PGC-like cells can be
abundantly generated with Go¨6983 or ZIP treatment, sug-
gesting that strategies that inhibit both PRKCi and/or
PRKCz may be useful to maintain stem cell self-renewal
and/or generate abundant PGC-like cells.DISCUSSION
In this report, we suggest that Prkci controls the balance be-
tween stem cell expansion and differentiation/mainte-
nance by regulating the activation of NUMB, NOTCH1,
and Hes /Hey downstream effector genes. In the absence
of Prkci, the pluripotent cell fate is favored, even without
LIF, yet cells still retain a broad capacity to differentiate.
In addition, loss of Prkci results in enhanced generation
of tissue progenitors such as neural stem cells and cardio-
myocyte and erythrocyte progenitors. In contrast to recent
findings on Prkcz (Dutta et al., 2011), loss of Prkci does not
appear to influence STAT3, AKT, or GSK3 signaling but re-
sults in decreased ERK1/2 activation. We hypothesize
that, in the absence of Prkci, although ERK1/2 inhibition
may be involved, it is the decreased NUMB phosphoryla-
tion and increased NOTCH1 activation that promotes
stem and progenitor cell fate. Thus, we conclude that
PRKCi, a protein known to be required for cell polarity,
also plays an essential role in controlling stem cell fate
and generation via regulating NOTCH1 activation.Notch Activation Drives the Decision to Self-Renew
versus Differentiate
Notch plays an important role in balancing stem cell self-
renewal and differentiation in a variety of stem cell types
and may be one of the key downstream effectors of Prkci876 Stem Cell Reports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 Thesignaling. Sustained Notch1 activity in embryonic neural
progenitors has been shown to maintain their undifferen-
tiated state (Jadhav et al., 2006). Similarly, sustained consti-
tutive activation of NOTCH1 stimulates the proliferation
of immature cardiomyocytes in the rat myocardium (Col-
lesi et al., 2008). In HSCs, overexpression of constitutively
active NOTCH1 in hematopoietic progenitors and stem
cells supports both primitive and definitive HSC self-
renewal (Stier et al., 2002). Together, these studies suggest
that activation and/or sustained Notch signaling can lead
to an increase in certain tissue stem cell populations.
Thus, a workingmodel for how tissue stem cell populations
are favored in the absence of Prkci involves a sequence of
events that ultimately leads to Notch activation. Recent
studies have shown that aPKCs can be found in a complex
with NUMB in both Drosophila and mammalian cells
(Smith et al., 2007; Zhou et al., 2011); hence, in our work-
ing model (Figure 5S), we propose that the localization and
phosphorylation of NUMB is highly dependent on the
activity of PRKCi. When Prkci is downregulated or absent
(as shown here), cell polarity is not promoted, leading to
diffuse distribution and decreased phosphorylation of
NUMB. Without active NUMB, NOTCH1 activation is
enhanced, Hes/Hey genes are upregulated, and stem/pro-
genitor fate generation is favored. To initiate differentia-
tion, polarization could be stochastically determined but
could also be dependent on external cues such as the pre-
sentation of certain ligands or extracellular matrix (ECM)
proteins (Habib et al., 2013). When PRKCi is active and
the cell becomes polarized, a trimeric complex is formed
with PRKCi, PAR3, and PAR6. Numb is then recruited and
phosphorylated, leading to Notch inactivation, the repres-
sion of downstream Hes/Hey genes, and differentiation is
favored (see Figure 5S). Support for this working model
comes from studies in Drosophila showing that the aPKC
complex is essential for Numb activation and asymmetric
localization (Knoblich, 2008; Smith et al., 2007; Wang
et al., 2006). Additional studies on mouse neural progeni-
tors show that regulating Numb localization and Notch
activation is critical for maintaining the proper number
of stem/progenitor cells in balance with differentiation
(Bultje et al., 2009). Thus, an important function for PRKCi
may be to regulate the switch between symmetric expan-
sion of stem/progenitor cells to an asymmetric differentia-
tion/maintenance phase. In situations of low or absent
PRKCi, we propose that the expansion phase is favored.
Thus, temporarily blocking either, or both, of the aPKC iso-
zymes may be a powerful approach for expanding specific
stem/progenitor populations for use in basic research or
for therapeutic applications.
These studies, together with data presented here, provide
genetic evidence that evolutionarily conserved polarity
pathways may play a central role in NOTCH1 activationAuthors
and stem cell self-renewal in mammals. Further genetic
studies usingCre transgenes that are specific for progenitors
in the neural plate, primitive erythrocytes, cardiomyo-
cytes, and other progenitors to ablate aPKC function will
be needed to determine how generally this mechanism is
used in diverse tissues.
Although we do not see changes in the activation status
of the STAT3, AKT, or GSK3 pathway, loss of Prkci results in
an inhibition of ERK1/2 (Figures 2A and 2B). This result is
consistent with the findings that ERK1/2 inhibition is
both correlated with and directly increases ES cell self-
renewal (Burdon et al., 1999). Modulation of ERK1/2
activity by Prkci has been observed in cancer cells and
chondrocytes (Litherland et al., 2010; Murray et al.,
2011). Although it is not clear whether a direct interaction
exists between Prkci and ERK1/2, Prkcz directly interacts
with ERK1/2 in the mouse liver and in hypoxia-exposed
cells (Das et al., 2008; Peng et al., 2008). The Prkcz isozyme
is still expressed in Prkci null cells but evidently cannot suf-
ficiently compensate and activate the pathway normally.
Furthermore, knocking down Prkcz function in ES cells
does not result in ERK1/2 inhibition, suggesting that this
isozyme does not impact ERK1/2 signaling in ES cells
(Dutta et al., 2011). Therefore, although PRKCi may
interact with ERK1/2 and be directly required for its activa-
tion, ERK1/2 inhibition could also be a readout for cells
that are more stem-like. Further studies will be needed to
address this question.
Utility of Inhibiting aPKC Function
Loss of Prkci resulted in EBs that contained slightly more
STELLA+ cells than EBs made from +/ cells. Furthermore,
inhibition of both aPKC isozymes by treating Prkci null
cells with the PKC inhibitor Go¨6983 or the more specific
inhibitor, ZIP, strongly promoted the generation of large
clusters of STELLA+ and VASA+ cells, suggesting that inhi-
bition of both isozymes is important for PGC progenitor
expansion (Figure 6). It is unclear what the mechanism
for this might be; however, one possibility is that blocking
both aPKCs is necessary to promote NOTCH1 activation in
PGCs or in PGC progenitor cells that may ordinarily have
strong inhibitions to expansion (Feng et al., 2014). Regard-
less of mechanism, the ability to generate PGC-like cells in
culture is notoriously challenging, and our results provide a
method for future studies on PGC specification and
differentiation.
Expansion of stem/progenitor poolsmay not be desirable
in the context of cancer. Prkci has been characterized as a
human oncogene, a useful prognostic cancer marker, and
a therapeutic target for cancer treatment. Overexpression
of Prkci is found in epithelial cancers (Fields and Regala,
2007), and Prkci inhibitors are being evaluated as candidate
cancer therapies (Atwood et al., 2013; Mansfield et al.,Stem Cell R2013). However, because our results show that Prkci inhibi-
tion leads to enhanced stem cell production in vitro, Prkci
inhibitor treatment as a cancer therapymight lead to unin-
tended consequences (tumor overgrowth), depending on
the context and treatment regimen. Thus, extending our
findings to human stem and cancer stem cells is needed.
In summary, here, we demonstrate that loss of Prkci leads
to the generation of abundant pluripotent cells, even under
differentiation conditions. In addition, we show that tissue
stem cells such as neural stem cells, primitive erythrocytes,
and cardiomyocyte progenitors can also be abundantly
produced in the absence of Prkci. These increases in stem
cell production correlate with decreased NUMB activation
and symmetric NUMB localization and require Notch
signaling. Further inhibition of Prkczmay have an additive
effect and can enhance the production of PGC-like cells.
Thus, Prkci (along with Prkcz) may play key roles in stem
cell self-renewal and differentiation by regulating the
Notch pathway. Furthermore, inhibition of Prkci and or
Prkcz activity with specific small-molecule inhibitorsmight
be a powerful method to boost stem cell production in the
context of injury or disease.EXPERIMENTAL PROCEDURES
Differentiation Assays
All animal procedures were carried out in accordance with
approved Animal Care and Use Protocols at the University of
SouthernCalifornia. Prkci/ embryo and ES cell derivation, EB cul-
ture, and confirmation of phenotype by lentiviral transfection
methods are described in the Supplemental Experimental Proce-
dures and Figure S1. To assay neural differentiation, EBs were
treated with 10 mM RA (Sigma; R2625-500MG) during days 2–6.
To assay cardiomyoctye differentiation, day 6 and day 12 EBs
were treated with 100 nM RA for 2 days. For the colony-forming
assay, EBs were dissociated into single cells (0.25% collagenase
type IV, GIBCO, 17104-019), resuspended in MethoCult GF
M3434 (Stem Cell Technologies), and cultured for 2 weeks.
For DAPT treatment, ES cells were cultured for 24 hr without LIF,
then for 4 days in 3 mM or 10 mM DAPT (Calbiochem, 565784) or
carrier (DMSO). Samples were assayed by immunofluoresence or
for alkaline phosphatase activity (Millipore, SCR004).
To inhibit aPKCs, ES cells were treated with 5 mM Go¨6983
(Sigma), 20 mM of the pseudo-substrate ZIP (Anaspec, 63361 Myr-
SIYRRGARRWRKL), or an equivalent amount of carrier (DMSO)
and then used to make EBs, which were treated with 5 mM
Go¨6983 or 20 mMZIP every other day. ZIP treatment did not affect
Prkcz RNA or protein expression levels (Figures S6G and S6H).
Immunofluorescence and sorting assays are described in the Sup-
plemental Experimental Procedures.
RNA Expression
Semiquantitative
Total RNA(RNeasyExtractionKit,QIAGEN)was reverse transcribed
using M-MuLV Reverse Transcriptase (New England Biolabs,eports j Vol. 5 j 866–880 j November 10, 2015 j ª2015 The Authors 877
M0253S) with random hexamers (Invitrogen, N8080127). See
Table S2 for PCR primer sequences.
RealTime Ready
Total RNA was isolated with the High Pure RNA Isolation Kit
(Roche) and reverse transcribed with the Transcriptor First Strand
cDNA Synthesis Kit (Roche). PCR was carried out using the
LightCycler 480 Probes Master Mix and a LightCycler 480
RealTime Ready custom plate (Roche). Unless otherwise noted,
expression was normalized to the mean expression of four refer-
ence genes (beta-actin, Gapdh, B2m, and Eef1a1).
Quantitative Analysis
The unpaired Student’s t test in Microsoft Excel was used to eval-
uate statistical significance. For doublet analysis, data are displayed
as a ratio of symmetric versus asymmetric localization, where the
value 1 represents both found equally (details in Supplemental
Experimental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2015.09.021.
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